 | • レポートコード：D0804-07833 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、100ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、麻疹ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。麻疹ワクチンの種類別市場規模（流行性耳下腺炎麻疹風疹ワクチン、生（MMR-II）、流行性耳下腺炎麻疹風疹および水痘ウイルスワクチン（プロクワッド））、用途別市場規模（子供、大人）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：GSK、Bavarian Nordic、Novartis、Sanofi-Pasteur、China National Biotech Group、Merck、Medimmune、Serum Institute of India、Pfizer、Emergent Biosolutions、Johnson & Johnson、CSL Limited ・地域別グローバル市場分析 2015年-2020年 ・麻疹ワクチンの北米市場（アメリカ、カナダ、メキシコ） ・麻疹ワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・麻疹ワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・麻疹ワクチンの南米市場（ブラジル、アルゼンチン） ・麻疹ワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：流行性耳下腺炎麻疹風疹ワクチン、生（MMR-II）、流行性耳下腺炎麻疹風疹および水痘ウイルスワクチン（プロクワッド） ・用途別分析：子供、大人 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Measles Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Measles Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Measles Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Measles Vaccine market has been segmented into
Mumps Measles Rubella Vaccine, Live (MMR-II)
Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
By Application, Measles Vaccine has been segmented into:
Children
Adults
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Measles Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Measles Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Measles Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Measles Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Measles Vaccine Market Share Analysis
Measles Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Measles Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Measles Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Measles Vaccine are:
GSK
Bavarian Nordic
Novartis
Sanofi-Pasteur
China National Biotech Group
Merck
Medimmune
Serum Institute of India
Pfizer
Emergent Biosolutions
Johnson & Johnson
CSL Limited
Among other players domestic and global, Measles Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Measles Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Measles Vaccine, with price, sales, revenue and global market share of Measles Vaccine in 2018 and 2019.
Chapter 3, the Measles Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Measles Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Measles Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Measles Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Measles Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Measles Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Mumps Measles Rubella Vaccine, Live (MMR-II)
1.2.3 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
1.3 Market Analysis by Application
1.3.1 Overview: Global Measles Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Children
1.3.3 Adults
1.4 Overview of Global Measles Vaccine Market
1.4.1 Global Measles Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GSK SWOT Analysis
2.1.4 GSK Product and Services
2.1.5 GSK Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bavarian Nordic
2.2.1 Bavarian Nordic Details
2.2.2 Bavarian Nordic Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bavarian Nordic SWOT Analysis
2.2.4 Bavarian Nordic Product and Services
2.2.5 Bavarian Nordic Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis SWOT Analysis
2.3.4 Novartis Product and Services
2.3.5 Novartis Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sanofi-Pasteur
2.4.1 Sanofi-Pasteur Details
2.4.2 Sanofi-Pasteur Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Sanofi-Pasteur SWOT Analysis
2.4.4 Sanofi-Pasteur Product and Services
2.4.5 Sanofi-Pasteur Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 China National Biotech Group
2.5.1 China National Biotech Group Details
2.5.2 China National Biotech Group Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 China National Biotech Group SWOT Analysis
2.5.4 China National Biotech Group Product and Services
2.5.5 China National Biotech Group Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck SWOT Analysis
2.6.4 Merck Product and Services
2.6.5 Merck Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Medimmune
2.7.1 Medimmune Details
2.7.2 Medimmune Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Medimmune SWOT Analysis
2.7.4 Medimmune Product and Services
2.7.5 Medimmune Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Serum Institute of India
2.8.1 Serum Institute of India Details
2.8.2 Serum Institute of India Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Serum Institute of India SWOT Analysis
2.8.4 Serum Institute of India Product and Services
2.8.5 Serum Institute of India Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Pfizer SWOT Analysis
2.9.4 Pfizer Product and Services
2.9.5 Pfizer Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Emergent Biosolutions
2.10.1 Emergent Biosolutions Details
2.10.2 Emergent Biosolutions Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Emergent Biosolutions SWOT Analysis
2.10.4 Emergent Biosolutions Product and Services
2.10.5 Emergent Biosolutions Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Johnson & Johnson
2.11.1 Johnson & Johnson Details
2.11.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Johnson & Johnson SWOT Analysis
2.11.4 Johnson & Johnson Product and Services
2.11.5 Johnson & Johnson Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 CSL Limited
2.12.1 CSL Limited Details
2.12.2 CSL Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 CSL Limited SWOT Analysis
2.12.4 CSL Limited Product and Services
2.12.5 CSL Limited Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Measles Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Measles Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Measles Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Measles Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Measles Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Measles Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Measles Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Measles Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Measles Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Measles Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Measles Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Measles Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Measles Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Measles Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Measles Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Measles Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Measles Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Measles Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Measles Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Measles Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Measles Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Measles Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Measles Vaccine Sales and Growth Rate (2015-2020)
6.4 France Measles Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Measles Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Measles Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Measles Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Measles Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Measles Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Measles Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Measles Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Measles Vaccine Sales and Growth Rate (2015-2020)
7.5 India Measles Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Measles Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Measles Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Measles Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Measles Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Measles Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Measles Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Measles Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Measles Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Measles Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Measles Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Measles Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Measles Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Measles Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Measles Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Measles Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Measles Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Measles Vaccine Price by Type (2015-2020)
11 Global Measles Vaccine Market Segment by Application
11.1 Global Measles Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Measles Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Measles Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Measles Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Measles Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Measles Vaccine Market Forecast (2021-2025)
12.2.2 Europe Measles Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Measles Vaccine Market Forecast (2021-2025)
12.2.4 South America Measles Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Measles Vaccine Market Forecast (2021-2025)
12.3 Measles Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Measles Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Measles Vaccine Market Share Forecast by Type (2021-2025)
12.4 Measles Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Measles Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Measles Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Measles Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Measles Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Measles Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Measles Vaccine Major Business
Table 9. GSK Measles Vaccine Total Revenue (USD Million) (2017-2018)
Table 10. GSK SWOT Analysis
Table 11. GSK Measles Vaccine Product and Services
Table 12. GSK Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table 14. Bavarian Nordic Measles Vaccine Major Business
Table 15. Bavarian Nordic Measles Vaccine Total Revenue (USD Million) (2017-2018)
Table 16. Bavarian Nordic SWOT Analysis
Table 17. Bavarian Nordic Measles Vaccine Product and Services
Table 18. Bavarian Nordic Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Novartis Basic Information, Manufacturing Base and Competitors
Table 20. Novartis Measles Vaccine Major Business
Table 21. Novartis Measles Vaccine Total Revenue (USD Million) (2017-2018)
Table 22. Novartis SWOT Analysis
Table 23. Novartis Measles Vaccine Product and Services
Table 24. Novartis Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Sanofi-Pasteur Basic Information, Manufacturing Base and Competitors
Table 26. Sanofi-Pasteur Measles Vaccine Major Business
Table 27. Sanofi-Pasteur Measles Vaccine Total Revenue (USD Million) (2017-2018)
Table 28. Sanofi-Pasteur SWOT Analysis
Table 29. Sanofi-Pasteur Measles Vaccine Product and Services
Table 30. Sanofi-Pasteur Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. China National Biotech Group Basic Information, Manufacturing Base and Competitors
Table 32. China National Biotech Group Measles Vaccine Major Business
Table 33. China National Biotech Group Measles Vaccine Total Revenue (USD Million) (2017-2018)
Table 34. China National Biotech Group SWOT Analysis
Table 35. China National Biotech Group Measles Vaccine Product and Services
Table 36. China National Biotech Group Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Merck Basic Information, Manufacturing Base and Competitors
Table 38. Merck Measles Vaccine Major Business
Table 39. Merck Measles Vaccine Total Revenue (USD Million) (2017-2018)
Table 40. Merck SWOT Analysis
Table 41. Merck Measles Vaccine Product and Services
Table 42. Merck Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Medimmune Basic Information, Manufacturing Base and Competitors
Table 44. Medimmune Measles Vaccine Major Business
Table 45. Medimmune Measles Vaccine Total Revenue (USD Million) (2017-2018)
Table 46. Medimmune SWOT Analysis
Table 47. Medimmune Measles Vaccine Product and Services
Table 48. Medimmune Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 50. Serum Institute of India Measles Vaccine Major Business
Table 51. Serum Institute of India Measles Vaccine Total Revenue (USD Million) (2017-2018)
Table 52. Serum Institute of India SWOT Analysis
Table 53. Serum Institute of India Measles Vaccine Product and Services
Table 54. Serum Institute of India Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Pfizer Basic Information, Manufacturing Base and Competitors
Table 56. Pfizer Measles Vaccine Major Business
Table 57. Pfizer Measles Vaccine Total Revenue (USD Million) (2017-2018)
Table 58. Pfizer SWOT Analysis
Table 59. Pfizer Measles Vaccine Product and Services
Table 60. Pfizer Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Emergent Biosolutions Basic Information, Manufacturing Base and Competitors
Table 62. Emergent Biosolutions Measles Vaccine Major Business
Table 63. Emergent Biosolutions Measles Vaccine Total Revenue (USD Million) (2017-2018)
Table 64. Emergent Biosolutions SWOT Analysis
Table 65. Emergent Biosolutions Measles Vaccine Product and Services
Table 66. Emergent Biosolutions Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 68. Johnson & Johnson Measles Vaccine Major Business
Table 69. Johnson & Johnson Measles Vaccine Total Revenue (USD Million) (2017-2018)
Table 70. Johnson & Johnson SWOT Analysis
Table 71. Johnson & Johnson Measles Vaccine Product and Services
Table 72. Johnson & Johnson Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 74. CSL Limited Measles Vaccine Major Business
Table 75. CSL Limited Measles Vaccine Total Revenue (USD Million) (2017-2018)
Table 76. CSL Limited SWOT Analysis
Table 77. CSL Limited Measles Vaccine Product and Services
Table 78. CSL Limited Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Global Measles Vaccine Sales by Manufacturer (2018-2019) (K MT)
Table 80. Global Measles Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 81. Global Measles Vaccine Sales by Regions (2015-2020) (K MT)
Table 82. Global Measles Vaccine Sales Market Share by Regions (2015-2020)
Table 83. Global Measles Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 84. North America Measles Vaccine Sales by Countries (2015-2020) (K MT)
Table 85. North America Measles Vaccine Sales Market Share by Countries (2015-2020)
Table 86. North America Measles Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 87. North America Measles Vaccine Revenue Market Share by Countries (2015-2020)
Table 88. Europe Measles Vaccine Sales by Countries (2015-2020) (K MT)
Table 89. Europe Measles Vaccine Sales Market Share by Countries (2015-2020)
Table 90. Europe Measles Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 91. Asia-Pacific Measles Vaccine Sales by Regions (2015-2020) (K MT)
Table 92. Asia-Pacific Measles Vaccine Sales Market Share by Regions (2015-2020)
Table 93. Asia-Pacific Measles Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 94. South America Measles Vaccine Sales by Countries (2015-2020) (K MT)
Table 95. South America Measles Vaccine Sales Market Share by Countries (2015-2020)
Table 96. South America Measles Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 97. South America Measles Vaccine Revenue Market Share by Countries (2015-2020)
Table 98. Middle East & Africa Measles Vaccine Sales by Countries (2015-2020) (K MT)
Table 99. Middle East & Africa Measles Vaccine Sales Market Share by Countries (2015-2020)
Table 100. Middle East & Africa Measles Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 101. Middle East & Africa Measles Vaccine Revenue Market Share by Countries (2015-2020)
Table 102. Global Measles Vaccine Sales by Type (2015-2020) (K MT)
Table 103. Global Measles Vaccine Sales Share by Type (2015-2020)
Table 104. Global Measles Vaccine Revenue by Type (2015-2020) (USD Million)
Table 105. Global Measles Vaccine Revenue Share by Type (2015-2020)
Table 106. Global Measles Vaccine Sales by Application (2015-2020) (K MT)
Table 107. Global Measles Vaccine Sales Share by Application (2015-2020)
Table 108. Global Measles Vaccine Sales Forecast by Regions (2021-2025) (K MT)
Table 109. Global Measles Vaccine Market Share Forecast by Regions (2021-2025)
Table 110. Global Measles Vaccine Sales Forecast by Type (2021-2025) (K MT)
Table 111. Global Measles Vaccine Market Share Forecast by Type (2021-2025)
Table 112. Global Measles Vaccine Sales Forecast by Application (2021-2025)
Table 113. Global Measles Vaccine Market Share Forecast by Application (2021-2025)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Measles Vaccine Picture
Figure 2. Global Sales Market Share of Measles Vaccine by Type in 2019
Figure 3. Mumps Measles Rubella Vaccine, Live (MMR-II) Picture
Figure 4. Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Picture
Figure 5. Measles Vaccine Sales Market Share by Application in 2018
Figure 6. Children Picture
Figure 7. Adults Picture
Figure 8. Global Measles Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Measles Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Measles Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Measles Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Measles Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Measles Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Measles Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Measles Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Measles Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Measles Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Measles Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Measles Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Measles Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Measles Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Measles Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Measles Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Measles Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Measles Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Measles Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Measles Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Measles Vaccine Sales Market Share by Manufacturer in 2019
Figure 29. Global Measles Vaccine Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Measles Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Measles Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Measles Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 34. Global Measles Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Measles Vaccine Revenue Market Share by Regions (2015-2020)
Figure 36. Global Measles Vaccine Revenue Market Share by Regions in 2018
Figure 37. North America Measles Vaccine Sales and Growth Rate (2015-2020)
Figure 38. Europe Measles Vaccine Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Measles Vaccine Sales and Growth Rate (2015-2020)
Figure 40. South America Measles Vaccine Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Measles Vaccine Sales and Growth Rate (2015-2020)
Figure 42. North America Measles Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Measles Vaccine Sales Market Share by Countries (2015-2020)
Figure 44. North America Measles Vaccine Sales Market Share by Countries in 2018
Figure 45. North America Measles Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Measles Vaccine Revenue Market Share by Countries in 2018
Figure 47. United States Measles Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 48. Canada Measles Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 49. Mexico Measles Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 50. Europe Measles Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Measles Vaccine Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Measles Vaccine Revenue Market Share by Countries in 2019
Figure 53. Germany Measles Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 54. UK Measles Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 55. France Measles Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 56. Russia Measles Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 57. Italy Measles Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 58. Asia-Pacific Measles Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Measles Vaccine Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Measles Vaccine Revenue Market Share by Regions 2019
Figure 61. China Measles Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 62. Japan Measles Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 63. Korea Measles Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 64. India Measles Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Southeast Asia Measles Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 66. South America Measles Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Measles Vaccine Sales Market Share by Countries in 2019
Figure 68. South America Measles Vaccine Revenue Market Share by Countries in 2019
Figure 69. Brazil Measles Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 70. Argentina Measles Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 71. Middle East and Africa Measles Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Measles Vaccine Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Measles Vaccine Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Measles Vaccine Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Measles Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 76. Egypt Measles Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 77. Turkey Measles Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 78. South Africa Measles Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 79. Global Measles Vaccine Sales and Growth Rate (2021-2025) (K MT)
Figure 80. Global Measles Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Measles Vaccine Market Forecast (2021-2025) (K MT)
Figure 82. Europe Sales Measles Vaccine Market Forecast (2021-2025) (K MT)
Figure 83. Asia-Pacific Sales Measles Vaccine Market Forecast (2021-2025) (K MT)
Figure 84. South America Sales Measles Vaccine Market Forecast (2021-2025) (K MT)
Figure 85. Middle East & Africa Sales Measles Vaccine Market Forecast (2021-2025) (K MT)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
水痘弱毒生ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Varicella Attenuated Live Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…- 帯状疱疹ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Shingles Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Shingles Vaccine market repo…
- ダニ媒介性脳炎ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Tick-borne Encephalitis Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tick-borne En…
- 新型コロナウイルス感染症用ワクチンの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Coronavirus Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- ピーナッツアレルギーワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Peanut Allergy Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Peanut Allergy Vaccine…